TrkA

From WikiMD's Food, Medicine & Wellness Encyclopedia

TrkA is a protein that in humans is encoded by the NTRK1 gene. It is a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Mutations in this gene have been associated with congenital insensitivity to pain with anhidrosis, self-mutilating behavior, mental retardation and cancer. It has a crucial role in the development and function of the nociceptive reception system as well as establishment of thermal regulation via sweating. It also activates ERK1 by either SHC1- or PLC-gamma1-dependent signaling pathway. Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis (CIPA).

Function[edit | edit source]

The TrkA protein is part of the large family of receptor tyrosine kinases. These receptors are responsible for receiving signals from outside the cell, which then cause a cellular response. Specifically, TrkA is involved in the growth, differentiation, and survival of neurons. It is activated by nerve growth factor (NGF), a molecule that is important for the development and survival of certain neurons.

Clinical significance[edit | edit source]

Mutations in the NTRK1 gene are associated with congenital insensitivity to pain with anhidrosis (CIPA), a condition characterized by insensitivity to pain, inability to sweat, and intellectual disability. The mutations that cause CIPA prevent the production of TrkA or result in the production of an abnormal receptor. Without functional TrkA, NGF cannot signal properly, leading to the death of sensory neurons and resulting in the signs and symptoms of CIPA.

See also[edit | edit source]

References[edit | edit source]


TrkA Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD